UCP1 and Hyperglycemia: The failure of the α-lipoic acid treatment to impact on insulin resistance, hyperglycemia and hyperinsulinemia indicates that factors other than oxidative stress and UCP-1 downregulation contribute to the glucose metabolic disorders in ZDF rats.